Yüklüyor......
High pemetrexed sensitivity of docetaxel-resistant A549 cells is mediated by TP53 status and downregulated thymidylate synthase
The chemoresistance of non-small cell lung cancer (NSCLC) that occurs in docetaxel (DOC) chemotherapy substantially decreases the survival of patients. To overcome DOC-induced chemoresistance, we established DOC-selected A549 lung cancer sublines (A549/D16 and A549/D32) and revealed that both sublin...
Kaydedildi:
| Yayımlandı: | Oncol Rep |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
D.A. Spandidos
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5780031/ https://ncbi.nlm.nih.gov/pubmed/28901493 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2017.5951 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|